Due Diligence in the Field of Chromatography for CDMOs, Biopharma, Pharma and Biotechs

CHALLENGE

A private equity firm commissioned a boutique consulting firm to conduct a due diligence project focused on chromatography in the contexts of Contract Development and Manufacturing Organizations (CDMOs), biopharma, pharma, and biotechs. The goal was to provide a thorough analysis of industry practices, trends, and key players to support informed investment decisions.

BTHT APPROACH

After an initial, in-depth consultation with the consulting firm and a detailed assessment of the project’s scope, the BTHT team quickly identified and engaged the most relevant experts. They reached out to senior manufacturing executives from leading CDMOs and pharmaceutical companies. These experts were selected for their extensive knowledge and experience in chromatography. The BTHT team arranged and facilitated a series of high-impact expert calls, ensuring that each conversation was insightful and free from technical disruptions.

OUTCOME

The BTHT team’s targeted approach enabled the private equity firm to connect with top manufacturing executives who provided critical insights into the chromatography landscape. The expert calls delivered valuable information on industry practices, technological advancements, and competitive dynamics. The client was notably impressed by the depth and quality of the insights provided, which significantly enhanced their understanding of the chromatography sector and supported their due diligence process. This thorough analysis proved crucial for making well-informed investment decisions in the field of chromatography.